Related Experiment Video
Updated: Mar 30, 2026
09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.8K
Total Pelvic Exenteration for Recurrent Endometrial Sarcoma - A Case Report.
Chirurgia (Bucharest, Romania : 1990)
|November 5, 2015
Summary
Endometrial stromal sarcoma is a rare cancer. This case study details a patient with recurrent endometrial stromal sarcoma treated with total pelvic exenteration.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
Background:
- Endometrial stromal sarcomas (ESS) are rare uterine malignancies originating from endometrial stromal cells.
- ESS are categorized into low-grade and high-grade subtypes based on mitotic index, with high-grade ESS associated with poorer prognosis and higher recurrence rates.
Observation:
- A 46-year-old female patient with a history of surgically treated endometrial stromal sarcoma and adjuvant radiotherapy presented with pelvic recurrence.
- The recurrence involved invasion of the urinary bladder trigone and rectosigmoid.
Findings:
- The patient underwent a total pelvic exenteration for the recurrent endometrial stromal sarcoma.
- This radical surgical approach addresses extensive pelvic recurrences of ESS.
Implications:
- Total pelvic exenteration can be a viable option for managing advanced or recurrent endometrial stromal sarcomas.
- Further research into optimal management strategies for recurrent ESS is warranted to improve patient outcomes.
